Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes

Abstract

OBJECTIVE: To provide information on the use and outcomes of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus (RSV) infection. DESIGN: Observational, prospective, longitudinal, multicenter study.

Authors

OH PI; LANCTÔT KL; YOON A; LEE DSC; PAES BA; SIMMONS BS; PARISON D; MANZI P

Journal

The Pediatric Infectious Disease Journal, Vol. 21, No. 6, pp. 512–518

Publisher

Wolters Kluwer

Publication Date

6 2002

DOI

10.1097/00006454-200206000-00007

ISSN

0891-3668

Associated Experts

Bosco Paes

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels